Editorial: Safety Pharmacology - Risk Assessment QT Interval Prolongation and Beyond

被引：5
|
作者：
Grandi, Eleonora [1 ]
Morotti, Stefano [1 ]
Pueyo, Esther [2 ]
Rodriguez, Blanca [3 ]
机构：
[1] Univ Calif Davis, Dept Pharmacol, Davis, CA 95616 USA
[2] Univ Zaragoza, Aragon Inst Engn Res, Biomed Signal Interpretat & Computat Simulat Grp, IIS Aragon, Zaragoza, Spain
[3] Univ Oxford, Dept Comp Sci, Oxford, England
来源：
FRONTIERS IN PHYSIOLOGY | 2018年 / 9卷
基金：
英国惠康基金;
关键词：
cardiotoxicity; QT interval prolongation; drug-induced arrhythmia; multi-scale modeling; cardiac electrophysiology; TORSADES-DE-POINTES; TRANSMURAL DISPERSION; MODELS; REPOLARIZATION; DRUGS; ELECTROPHYSIOLOGY; CONVERGENCE; SIMULATION; PREDICTION; DYNAMICS;
D O I：
10.3389/fphys.2018.00678
中图分类号：
Q4 [生理学];
学科分类号：
071003 ;
摘要：
引用
收藏
页数：5
相关论文
共 50 条
  • [31] The effect of intravenous haloperidol on QT interval dispersion in critically ill patients: Comparison with QT interval prolongation for assessment of risk of Torsades de Pointes
    Tisdale, JE
    Rasty, S
    Padhi, ID
    Sharma, ND
    Rosman, H
    JOURNAL OF CLINICAL PHARMACOLOGY, 2001, 41 (12): : 1310 - 1318
  • [32] Preferred QT correction formula for the assessment of drug-induced QT interval prolongation
    Chiladakis, I.
    Kalogeropoulos, A.
    Arvanitis, P.
    Koutsogiannis, N.
    Zagli, F.
    Alexopoulos, D.
    EUROPEAN HEART JOURNAL, 2010, 31 : 266 - 266
  • [33] Preferred QT Correction Formula for the Assessment of Drug-Induced QT Interval Prolongation
    Chiladakis, John
    Kalogeropoulos, Andreas
    Arvanitis, Panagiotis
    Koutsogiannis, Nikolaos
    Zagli, Fani
    Alexopoulos, Dimitrios
    JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2010, 21 (08) : 905 - 913
  • [34] The assessment of QT/QTc interval prolongation in clinical trials: A regulatory perspective
    Strnadova, C
    DRUG INFORMATION JOURNAL, 2005, 39 (04): : 407 - 433
  • [35] The Assessment of QT/QTc Interval Prolongation in Clinical Trials: A Regulatory Perspective
    Colette Strnadova
    Drug information journal : DIJ / Drug Information Association, 2005, 39 : 407 - 435
  • [36] Antipsychotic drugs and QT interval prolongation
    Zareba, W
    Lin, DA
    PSYCHIATRIC QUARTERLY, 2003, 74 (03) : 291 - 306
  • [37] Outcomes from QT prolongation risk assessment studies
    Patmore, L
    MacFarlane, K
    Lansdell, K
    Templeton, A
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2004, 94 : 107P - 107P
  • [38] QT interval prolongation: And the beat goes on
    Jalaie, M
    Holsworth, DD
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2005, 5 (12) : 1083 - 1091
  • [39] Oxytocin induces QT interval prolongation
    Reactions Weekly, 2004, 1029 (1) : 4 - 4
  • [40] QT Interval Prolongation in Cirrhotic Cardiomyopathy
    Tadelle, Amanuel
    RESEARCH REPORTS IN CLINICAL CARDIOLOGY, 2022, 13 : 55 - 61
12345